Cell and Gene Therapy Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend and Growth Opportunity Analysis Report Coverage: By Type, Services, Scale, Service Providers, End User and Geography

The cell and gene therapy market is expected to grow from US$ 4.48 billion in 2023 to US$ 28.05 billion by 2031; it is anticipated to record a CAGR of 25.8% from 2023 to 2031.

Key segments that contributed to the derivation of the cell and gene therapy market analysis are services, scale, service providers, and end user.

The cell and gene therapy market, by type, the cell and gene therapy market is segmented into bifurcated into cell therapy, gene therapy. The cell therapy segment held a larger market share in 2023. Cell therapy helps treat disorders and diseases by restoring or changing certain groups of cells or providing cells to carry therapy through the body. Cell therapy forms or modifies cells outside the body before introducing into the patient. The cells might derive from the patient (autologous cells) or a donor (allogeneic cells). The growth of the cell therapy segment is attributed to the increasing number of products entering the market, the potential application of cell therapies in treating autoimmune diseases, cancer, and infectious diseases, and the high number of ongoing clinical trials.

The cell and gene therapy market, by services, the market is segmented into process development, cGMP manufacturing, regulatory services, bioassay services. The process development segment held a larger share of the market in 2023. The cell and gene therapy market is witnessing rapid growth driven by technological advancements, particularly in manufacturing and delivery services. With such advancements, cell and gene therapy developers offer expertise in developing robust and scalable manufacturing processes, ensuring high-quality product consistency, and optimizing delivery methods for specific therapeutic targets.

By type, the market is segmented into vented and non-vented. The vented segment held a larger share of the market in 2023.

The cell and gene therapy market, by scale, the market is bifurcated into pre commercial/R and D manufacturing, commercial scale manufacturing. The pre commercial/R and D manufacturing segment held a larger share of the market in 2023.

The cell and gene therapy market, by service provider, the market is divided into CDMOs, CMOs. The CDMOs segment held a larger share of the market in 2023.

The cell and gene therapy market, by end user, the market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, academic and research institutes. The pharmaceutical and biopharmaceutical companies segment dominated the market in 2023.

The scope of the cell and gene therapy market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). In terms of revenue, North America accounted for the largest market share in 2023. On the other hand, Asia Pacific region accounted for the fastest-growing global cell and gene therapy market in 2023. China is making progress in gene and cell therapy.

The country has a large patient population making it an attractive market for companies developing these treatments. Several companies are working on innovative therapies for diseases such as cancer and genetic disorders in China, and the country has invested heavily in gene therapy research and development. China was the first country to approve gene therapy in 2003; since then, cell and gene therapy developments have advanced rapidly worldwide, and their therapeutic potential has soared. The government of the People's Republic of China has conducted several regulatory reforms to promote the normative development of cell and gene therapies. In addition, the presence of various market leaders operating in the segments is contributing to the market expansion, which contribute notably to the expansion of cell and gene therapy market size.

European Union (EU), Organisation for Economic Co-operation and Development (OECD), and National Library of Medicine (NLM) are a few key primary and secondary sources referred to while preparing the report on the cell and gene therapy market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the cell and gene therapy market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the cell and gene therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the cell and gene therapy market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Cell and Gene Therapy Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Cell and Gene Therapy Market - Key Market Dynamics

5.1 Cell and Gene Therapy Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increase in Number of Approval of Cell and Gene Therapies
5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.3 Market Restraints
5.3.1 High Cost of Cell and Gene Therapy Manufacturing
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
5.6 Impact of Drivers and Restraints:

6. Cell and Gene Therapy Market - Global Market Analysis

6.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
6.2 Cell and Gene Therapy Market Forecast Analysis

7. Cell and Gene Therapy Market Analysis - by Type

7.1 Cell Therapy
7.1.1 Overview
7.1.2 Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
7.2.1 Overview
7.2.2 Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

8. Cell and Gene Therapy Market Analysis - by Services

8.1 Process Development
8.1.1 Overview
8.1.2 Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.2 cGMP Manufacturing
8.2.1 Overview
8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Regulatory Services
8.3.1 Overview
8.3.2 Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Bioassay Services
8.4.1 Overview
8.4.2 Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

9. Cell and Gene Therapy Market Analysis - by Scale

9.1 Pre Commercial/R and D Manufacturing
9.1.1 Overview
9.1.2 Pre Commercial/R and D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Commercial Scale Manufacturing
9.2.1 Overview
9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

10. Cell and Gene Therapy Market Analysis - by Service Providers

10.1 CDMOs
10.1.1 Overview
10.1.2 CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10.2 CMOs
10.2.1 Overview
10.2.2 CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

11. Cell and Gene Therapy Market Analysis - by End User

11.1 Contract Research Organizations
11.1.1 Overview
11.1.2 Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Pharmaceutical and Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Academic and Research Institutes
11.3.1 Overview
11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

12. Cell and Gene Therapy Market - Geographical Analysis

12.1 Overview
12.2 North America
12.2.1 North America Cell and Gene Therapy Market Overview
12.2.2 North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.2.3 North America: Cell and Gene Therapy Market Breakdown, by Type
12.2.3.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
12.2.3.1.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
12.2.3.1.2 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
12.2.4 North America: Cell and Gene Therapy Market Breakdown, by Services
12.2.4.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
12.2.5 North America: Cell and Gene Therapy Market Breakdown, by Scale
12.2.5.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
12.2.6 North America: Cell and Gene Therapy Market Breakdown, by Service Providers
12.2.6.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
12.2.7 North America: Cell and Gene Therapy Market Breakdown, by End User
12.2.7.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
12.2.8 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.2.8.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.2.8.2 United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.2.8.2.1 United States: Cell and Gene Therapy Market Breakdown, by Type
12.2.8.2.1.1 United States: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.2.8.2.1.2 United States: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.2.8.2.2 United States: Cell and Gene Therapy Market Breakdown, by Services
12.2.8.2.3 United States: Cell and Gene Therapy Market Breakdown, by Scale
12.2.8.2.4 United States: Cell and Gene Therapy Market Breakdown, by Service Providers
12.2.8.2.5 United States: Cell and Gene Therapy Market Breakdown, by End User
12.2.8.3 Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.2.8.3.1 Canada: Cell and Gene Therapy Market Breakdown, by Type
12.2.8.3.1.1 Canada: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.2.8.3.1.2 Canada: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.2.8.3.2 Canada: Cell and Gene Therapy Market Breakdown, by Services
12.2.8.3.3 Canada: Cell and Gene Therapy Market Breakdown, by Scale
12.2.8.3.4 Canada: Cell and Gene Therapy Market Breakdown, by Service Providers
12.2.8.3.5 Canada: Cell and Gene Therapy Market Breakdown, by End User
12.2.8.4 Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.2.8.4.1 Mexico: Cell and Gene Therapy Market Breakdown, by Type
12.2.8.4.1.1 Mexico: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.2.8.4.1.2 Mexico: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.2.8.4.2 Mexico: Cell and Gene Therapy Market Breakdown, by Services
12.2.8.4.3 Mexico: Cell and Gene Therapy Market Breakdown, by Scale
12.2.8.4.4 Mexico: Cell and Gene Therapy Market Breakdown, by Service Providers
12.2.8.4.5 Mexico: Cell and Gene Therapy Market Breakdown, by End User
12.3 Europe
12.3.1 Europe Cell and Gene Therapy Market Overview
12.3.2 Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.3.3 Europe: Cell and Gene Therapy Market Breakdown, by Type
12.3.3.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
12.3.3.1.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
12.3.3.1.2 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
12.3.4 Europe: Cell and Gene Therapy Market Breakdown, by Services
12.3.4.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
12.3.5 Europe: Cell and Gene Therapy Market Breakdown, by Scale
12.3.5.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
12.3.6 Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.6.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
12.3.7 Europe: Cell and Gene Therapy Market Breakdown, by End User
12.3.7.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
12.3.8 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.3.8.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.3.8.2 United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.3.8.2.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.2.1.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.2.1.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.2.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.2.3 United Kingdom: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.2.4 United Kingdom: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.2.5 United Kingdom: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.3 Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.3.8.3.1 Germany: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.3.1.1 Germany: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.3.1.2 Germany: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.3.2 Germany: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.3.3 Germany: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.3.4 Germany: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.3.5 Germany: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.4 France: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.3.8.4.1 France: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.4.1.1 France: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.4.1.2 France: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.4.2 France: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.4.3 France: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.4.4 France: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.4.5 France: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.5 Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.3.8.5.1 Italy: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.5.1.1 Italy: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.5.1.2 Italy: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.5.2 Italy: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.5.3 Italy: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.5.4 Italy: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.5.5 Italy: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.6 Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.3.8.6.1 Spain: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.6.1.1 Spain: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.6.1.2 Spain: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.6.2 Spain: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.6.3 Spain: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.6.4 Spain: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.6.5 Spain: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.7 Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.3.8.7.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.7.1.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.7.1.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.7.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.7.3 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.7.4 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.7.5 Rest of Europe: Cell and Gene Therapy Market Breakdown, by End User
12.4 Asia Pacific
12.4.1 Asia Pacific Cell and Gene Therapy Market Overview
12.4.2 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.4.3 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Type
12.4.3.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
12.4.3.1.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
12.4.3.1.2 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
12.4.4 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Services
12.4.4.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
12.4.5 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Scale
12.4.5.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
12.4.6 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.6.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
12.4.7 Asia Pacific: Cell and Gene Therapy Market Breakdown, by End User
12.4.7.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
12.4.8 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.4.8.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.4.8.2 China: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.4.8.2.1 China: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.2.1.1 China: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.2.1.2 China: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.2.2 China: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.2.3 hina: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.2.4 China: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.2.5 China: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.3 Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.4.8.3.1 Japan: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.3.1.1 Japan: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.3.1.2 Japan: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.3.2 Japan: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.3.3 Japan: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.3.4 Japan: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.3.5 Japan: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.4 India: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.4.8.4.1 India: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.4.1.1 India: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.4.1.2 India: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.4.2 India: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.4.3 India: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.4.4 India: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.4.5 India: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.5 Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.4.8.5.1 Australia: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.5.1.1 Australia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.5.1.2 Australia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.5.2 Australia: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.5.3 Australia: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.5.4 Australia: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.5.5 Australia: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.6 South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.4.8.6.1 South Korea: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.6.1.1 South Korea: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.6.1.2 South Korea: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.6.2 South Korea: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.6.3 South Korea: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.6.4 South Korea: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.6.5 South Korea: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.7 Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.4.8.7.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.7.1.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.7.1.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.7.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.7.3 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.7.4 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.7.5 Rest of APAC: Cell and Gene Therapy Market Breakdown, by End User
12.5 Middle East and Africa
12.5.1 Middle East and Africa Cell and Gene Therapy Market Overview
12.5.2 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.5.3 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
12.5.3.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
12.5.3.1.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
12.5.3.1.2 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
12.5.4 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
12.5.4.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
12.5.5 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
12.5.5.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
12.5.6 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.6.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
12.5.7 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
12.5.7.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
12.5.8 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.5.8.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.5.8.2 South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.5.8.2.1 South Africa: Cell and Gene Therapy Market Breakdown, by Type
12.5.8.2.1.1 South Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.5.8.2.1.2 South Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.5.8.2.2 South Africa: Cell and Gene Therapy Market Breakdown, by Services
12.5.8.2.3 South Africa: Cell and Gene Therapy Market Breakdown, by Scale
12.5.8.2.4 South Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.8.2.5 South Africa: Cell and Gene Therapy Market Breakdown, by End User
12.5.8.3 Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.5.8.3.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Type
12.5.8.3.1.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.5.8.3.1.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.5.8.3.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Services
12.5.8.3.3 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Scale
12.5.8.3.4 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.8.3.5 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by End User
12.5.8.4 United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.5.8.4.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Type
12.5.8.4.1.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.5.8.4.1.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.5.8.4.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Services
12.5.8.4.3 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Scale
12.5.8.4.4 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.8.4.5 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by End User
12.5.8.5 Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.5.8.5.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
12.5.8.5.1.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.5.8.5.1.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.5.8.5.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
12.5.8.5.3 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
12.5.8.5.4 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.8.5.5 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
12.6 South and Central America
12.6.1 South and Central America Cell and Gene Therapy Market Overview
12.6.2 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.6.3 South and Central America: Cell and Gene Therapy Market Breakdown, by Type
12.6.3.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
12.6.3.1.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
12.6.3.1.2 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
12.6.4 South and Central America: Cell and Gene Therapy Market Breakdown, by Services
12.6.4.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
12.6.5 South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
12.6.5.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
12.6.6 South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
12.6.6.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
12.6.7 South and Central America: Cell and Gene Therapy Market Breakdown, by End User
12.6.7.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
12.6.8 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.6.8.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.6.8.2 Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.6.8.2.1 Brazil: Cell and Gene Therapy Market Breakdown, by Type
12.6.8.2.1.1 Brazil: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.6.8.2.1.2 Brazil: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.6.8.2.2 Brazil: Cell and Gene Therapy Market Breakdown, by Services
12.6.8.2.3 Brazil: Cell and Gene Therapy Market Breakdown, by Scale
12.6.8.2.4 Brazil: Cell and Gene Therapy Market Breakdown, by Service Providers
12.6.8.2.5 Brazil: Cell and Gene Therapy Market Breakdown, by End User
12.6.8.3 Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.6.8.3.1 Argentina: Cell and Gene Therapy Market Breakdown, by Type
12.6.8.3.1.1 Argentina: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.6.8.3.1.2 Argentina: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.6.8.3.2 Argentina: Cell and Gene Therapy Market Breakdown, by Services
12.6.8.3.3 Argentina: Cell and Gene Therapy Market Breakdown, by Scale
12.6.8.3.4 Argentina: Cell and Gene Therapy Market Breakdown, by Service Providers
12.6.8.3.5 Argentina: Cell and Gene Therapy Market Breakdown, by End User
12.6.8.4 Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.6.8.4.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Type
12.6.8.4.1.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.6.8.4.1.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.6.8.4.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Services
12.6.8.4.3 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
12.6.8.4.4 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
12.6.8.4.5 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in Cell and Gene Therapy Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview

14. Company Profiles

14.1 Thermo Fisher Scientific Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Merck KGaA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Cell and Gene Therapy Catapult
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Lonza Group AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 WuXi AppTec Co Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Takara Bio Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 FUJIFILM Holdings Corp
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 F. Hoffmann-La Roche Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Catalent Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Lotte Corp
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

15. Appendix

15.1 About The Publisher
15.2 Glossary of Terms

Companies Mentioned

North America Virtual Pipeline Equipment Market
Chesapeake Utilities Corp
Stabilis Solutions Inc
Algas-SDI International LLC
ANGI Energy Systems LLC
Broadwind Inc
Cobey Inc
Cryopeak LNG Solutions Corp
Galileo Technologies SA
Quantum Fuel Systems LLC
Hexagon Composites ASA

Table Information

Report Attribute	Details
No. of Pages	232
Published	August 2024
Forecast Period	2023 - 2031
Estimated Market Value in 2023	4.48 Billion
Forecasted Market Value by 2031	28.05 Billion
Compound Annual Growth Rate	25.8%
Regions Covered	Global
No. of Companies Mentioned	11

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3466EUR$3,633USD£2,904GBP €4952EUR$5,190USD£4,148GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4802EUR$5,033USD£4,023GBP €6860EUR$7,190USD£5,746GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€6138EUR$6,433USD£5,141GBP €8768EUR$9,190USD£7,345GBP

Reasons to Buy:

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO) Global Market Report 2024

Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029

Cell and Gene Therapy Global Market Report 2024

Cell and Gene Therapy CDMO Market: Analysis By Type, Application, Indication, By Region, By Country: Market Insights and Forecast

Global Cell and Gene Therapy Market